MCCC Lecture to Focus on
U.S. Drug Approval Process April 8


Dr. Ronald Harning, director of clinical research and regulatory affairs at Teijin America, Inc., will present "Drug Approval in the U.S.: A Review of the Process and Potential Career Opportunities" on Tuesday, April 8, at 12 noon at Mercer County Community College (MCCC). The talk takes place in Room 109 in the Communications Building on Mercer's West Windsor campus, 1200 Old Trenton Road. Part of Mercer's Distinguished Lecture Series, it is free and open to the public.

"Dr. Harning is back at Mercer by popular demand," said Dr. Diane Hilker, associate professor of biology at MCCC. "He spoke on campus in 2005 on the biology of cancer. His broad background in the pharmaceutical field will be of great interest to those in the allied health fields, especially to those who wish to explore potential careers in both pre-clinical and clinical aspects of drug development."

Dr. Ronald Harning

Dr. Harning's 23-year career in the drug development industry started in preclinical research, with an examination of the effect of anti-cell adhesion molecule antibodies on the process of tumor growth, invasion, and metastasis in animal and in vitro models of cancer. For the past 17 years, he has been employed in both large and small pharmaceutical companies on the clinical research side of drug development. He has published broadly in the areas of oncology, bone metabolism, and sexual dysfunction. Dr. Harning received his Ph.D. in molecular biology from The City University of New York.

Over the years, Dr. Harning has been an active member of the American Society of Clinical Oncologists, the American Association for Cancer Research, and a member and Fellow of the American Academy of Allergy and Immunology.

To learn more about MCCC's spring lectures, click here or call 609-570-3324.

Directions to MCCC

Return to What's New